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permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.SUMMARYCell banking, disease modeling, and cell therapy applications have placed increasing demands on hiPSC technology. Specifically, the
high-throughput derivation of footprint-free hiPSCs and their expansion in systems that allow scaled production remains technically
challenging. Here, we describe a platform for the rapid, parallel generation, selection, and expansion of hiPSCs using small molecule
pathway inhibitors in stage-specificmedia compositions. The platform supported efficient and expedited episomal reprogramming using
just OCT4/SOX2/SV40LT combination (0.5%–4.0%, between days 12 and 16) in a completely feeder-free environment. The resulting
hiPSCs are transgene-free, readily cultured, and expanded as single cells while maintaining a homogeneous and genomically stable
pluripotent population. hiPSCs generated or maintained in the media compositions described exhibit properties associated with the
ground state of pluripotency. The simplicity and robustness of the system allow for the high-throughput generation and rapid expansion
of a uniform hiPSC product that is applicable to industrial and clinical-grade use.INTRODUCTION
Today’s human induced pluripotent stem cell (hiPSC)-
based disease and toxicology screening efforts and tomor-
row’s hiPSC-based auto/allogeneic cell therapies will
require robust, reproducible methods of cell line genera-
tion and expansion, without the integration of the reprog-
ramming factor transgenes (Saha and Jaenisch, 2009).
hiPSCs were first generated by the ectopic expression of
multiple genes introduced through genome-integrating
retro- and lentiviral expression systems: namely OCT4
(POU5F1), SOX2, cMYC,KLF4, LIN28, andNANOG (Takaha-
shi et al., 2007; Yu et al., 2007). To eliminate as many inte-
grating events as possible, several studies were able to
substitute unique small molecule inhibitors for a number
of reprogramming factors (Nie et al., 2012). The derivation
of footprint-free hiPSCs has been demonstrated using
several nonintegrative strategies, including episomal-,
RNA-, Sendai virus-, and protein-based methods (Fusaki
et al., 2009; Warren et al., 2010; Yu et al., 2009; Zhou
et al., 2009). However, nonintegrative methods have
proven to be inefficient and labor intensive, often
requiring additional reprogramming factors (Lee et al.,
2013).
In the most commonly used conventional culture
system, human embryonic stem cells (hESCs) and hiPSCs
are maintained on feeder cells while passaged as clumps
to prevent extensive cell death and genomic aberrations
(Thomson et al., 1998). The inability to single-cell culture
hiPSCs in a feeder-free (FF) environment severely limits366 Stem Cell Reports j Vol. 2 j 366–381 j March 11, 2014 j ª2014 The Authpotential industrial scale screening or cell therapy applica-
tions (Valamehr et al., 2011). Recent efforts focused on
improving single-cell survival have identified small mole-
cule inhibition of the Rho-associated protein kinase to
dramatically reduce cell death upon single-cell dissociation
(Watanabe et al., 2007; Xu et al., 2010). More recently, we
have demonstrated efficient single-cell and FF culture of
lentiviral-derived hiPSCs in the presence of a small
molecule cocktail, SMC4 (Valamehr et al., 2012). By inhib-
iting pathways associated with cell death and differentia-
tion, we were able to achieve high-resolution direct flow
cytometry sorting and maintenance of hiPSCs in a
completely FF system (Abujarour et al., 2013; Valamehr
et al., 2012). However, our study focused on lentiviral-
derived hiPSCs that were not transgene-free, limiting its
therapeutic relevance. Another challenge in pluripotent
stem cell culture is their propensity for spontaneous
differentiation (Pera and Trounson, 2004; Valamehr et al.,
2011). This issue has been resolved for mouse pluripotent
stem cells: by blocking differentiation cues of mouse ESCs
in culture through small molecule inhibition of mitogen-
activated protein kinase and glycogen synthase kinase 3
(termed ‘‘2i’’), the ground state of pluripotency was
achieved, and spontaneous differentiation of mouse
ESCs was prevented (Ying et al., 2008). Similar studies in
hESCs have been described; however, continuous ectopic
expression of pluripotency genes was necessary to main-
tain the ground state resulting in genome-modified human
pluripotent stem cells (Hanna et al., 2010a; Wang et al.,
2011).ors
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Transgene-free hiPSCs Resembling the Ground StateHere, we describe a multistage culture platform that en-
ables highly efficient episomal reprogramming with a sig-
nificant reduction in time and effort for hiPSC generation
and using just aminimal number of reprogramming factors
(OCT4/SOX2/SV40LT). Furthermore, the system can be
multiplexed to allow for parallel reprogramming and char-
acterization of multiple somatic cell lines with ease and in
an expedited time: bona fide hiPSCs are individually flow
cytometry sorted into 96-well plates, characterized, and
readily expanded with minimal hands-on effort. We
describe improvements inmedium composition that allow
long-term maintenance of transgene-free hiPSCs in single-
cell and FF passage culture with genomic stability and
minimal evidence of spontaneous differentiation. Further-
more, gene expression analysis shows that small molecule
inhibition of specific signaling pathways may drive hiPSCs
to a common ground state of pluripotency, regardless of
genetic background and independent of transgene expres-
sion. We believe that this demonstration of stable culture
of transgene/footprint-free hiPSCs as single cells in a FF
environment with the elimination of spontaneous differ-
entiationwill serve as a valuable asset in drivingpluripotent
stem cell technology toward clinical applications.RESULTS
Identifying Medium Compositions for Long-term
Maintenance and Expansion of hiPSCs
We have previously demonstrated improved reprogram-
ming efficiencies and single-cell enzymatic, FF passaging
of lentiviral-derived hiPSCs using a small molecule cocktail
containing ROCK, GSK3, MEK, and TGF-b pathway inhib-
itors, termed SMC4 (Valamehr et al., 2012). Although the
majority of lentiviral-derived hiPSC lines in SMC4-supple-
mented culturesmaintained a homogeneous population of
undifferentiated cells, a subset of lines displayed various
degrees of spontaneous differentiation on extended culture
(Figure 1A). Analysis of the viral WPRE regulatory element
revealed that silencing of the reprogramming factor trans-
gene in the hiPSC lines correlated with the observed spon-
taneous differentiation (Figure 1B). We therefore initiated
an assessment of the cell culture components, including
the small molecule inhibitors, in order to identify whether
a homogeneous pluripotent population could be main-
tained during continuous culture on FF and single-cell
enzymatic passage regardless of residual transgene expres-
sion. We observed that inhibition of the TGF-b pathway
during long-term maintenance was the most significant
factor in inducing the spontaneous differentiation of
hiPSC lines with silenced transgene expression (Figure 1C).
This observation was consistent with previous studies
demonstrating that the TGF-b pathway plays opposingStem Croles in reprogramming and maintenance (Beattie et al.,
2005; Lin et al., 2009). We therefore derived a medium
formulation: Fatemaintenancemedium (FMM) containing
ROCK, GSK3, andMEK pathway inhibitors, basic fibroblast
growth factor (bFGF), and leukemia inhibitory factor (LIF)
(Table S1 available online). When hiPSC clone FTi096
was directly transitioned to FMM, themajority of the spon-
taneous differentiation was eliminated within two to three
passages, without the need for additional culture manipu-
lation, resulting in a homogeneous population of SSEA4/
TRA181-positive cells (Figure 1A).
To test whether FMM can completely replace SMC4-
supplemented medium during the reprogramming
process, we initiated OCT4/KLF4/SOX2 (OKS) lentiviral
reprogramming in conventional culture (hESC medium
on mouse embryonic fibroblast [MEF] feeder cells), SMC4-
supplemented medium in FF culture, or FMM in FF culture
(Figure 1D). Seventeen days after the induction of lentiviral
reprogramming, the cells from each culture were flow
cytometry sorted, and cells positive for SSEA4/TRA181
were selected and replated in their respective culture
media. The reprogramming cells from the SMC4 culture
were replated in either SMC4 or FMM for comparison (Fig-
ure 1D). As previously seen, SMC4 dramatically improved
the kinetics of reprogramming, resulting in significantly
more SSEA4/TRA181-positive cells at day 17 postinduction
(2.72% versus 0.76% for FMM and 0.10% for conventional
culture; Figure 1D) (Valamehr et al., 2012). The cultures
were maintained for a total of 36 days postinfection and
scored for undifferentiated colonies (Figures 1D and 1E).
The combination of initial reprogramming in SMC4
followed by a transition to FMM ultimately resulted in
more OCT4/NANOG-positive colonies and a significantly
reduced number of OCT4/NANOG-negative colonies rela-
tive to continuous maintenance in SMC4 (Figures 1D and
1E). In cultures maintained exclusively in FMM, the
number and size of the colonies appeared inferior to the
stage-specific media approach. Cultures continuously
maintained in conventional hESC media on feeder cells
did not produce any OCT4/NANOG colonies, consistent
with the low efficiencies seen by OKS reprogramming
when unaided by small molecules (Nakagawa et al.,
2008). Therefore, a multistage culture system that targets
unique pathways at different stages of the reprogramming
and maintenance process appears to be the most efficient
and robust approach to hiPSC generation.
Multiplex Generation, Characterization, and
Maintenance of Transgene-free hiPSCs in a Single-Cell
Passage and FF Format
Although attractive for clinical use, episomal vector
systems for nonintegrative reprogramming are extremely
inefficient (<0.001%), especially in FF environmentsell Reports j Vol. 2 j 366–381 j March 11, 2014 j ª2014 The Authors 367
Figure 1. Multistage Medium Platform for Enhanced Reprogramming and hiPSC Maintenance
(A) Lentiviral-generated hiPSC clones FTi088 and FTi096 cultured in SMC4. The spontaneous differentiation of clone FTi096 is minimized
when transitioned to FMM for three passages shown by morphology (upper panels) and flow cytometry profile (lower panels). Scale bars,
1,000 mm.
(B) Quantitative real-time PCR for transgene expression of viral element WPRE. Expression was normalized to GAPDH and relative to WPRE
expressionof parental fibroblast line 4days post-lentiviral infection (Day4 P.I.). Three independent experimentswere performedwith anSEM.
(C) SSEA4 and TRA181 status of transgene-silenced lenti-induced hiPSCs in various components: removal of SB431542 (TGF-bi),
100 ng/ml bFGF (+100 bFGF), and 10 ng/ml LIF (+10 LIF). Three independent experiments were performed with an SEM.
(D) Fibroblast line was transfected with lentiviral construct containing gene set OKS, cultured, and sorted as indicated. Sort gate is
highlighted in blue. At day 27, the cultures were resorted, seeded at normalized density, and maintained in respective media for an
additional 9 days. Panels on the right are representative colonies. Scale bars, 500 mm.
(legend continued on next page)
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Transgene-free hiPSCs Resembling the Ground State(Narsinh et al., 2011; O’Doherty et al., 2013). We therefore
assessed whether episomal induction would be best sup-
ported by a multistage culture system. We adapted our
hiPSC generation platform as outlined in Figure 2A: 24 hr
after induction of episomal expression, the reprogramming
culture is transitioned to Fate-reprogrammingmedia (FRM)
to enhance reprogramming kinetics, and at day 14, the
culture is switched to FMM to promote hiPSC proliferation
in an undifferentiated state. Between days 16 and 22, the
culture is flow cytometry analyzed for individual hiPSCs
using a cocktail of surface markers geared for identification
of bona fide hiPSCs (Abujarour et al., 2013) and directly
sorted into FF 96-well plates at clonal densities, i.e., three
events per well. The 96-well plates are then surveyed by
various criteria including expression of key pluripotency
markers, and selected hiPSC clones are expanded as single
cells in a FF environment with FMM (Figure 2A).
In a pilot study, an episomal expression systemconsisting
of gene combination OCT4/SOX2/NANOG/KLF4/LIN28/
MYC/SV40LT (OSNKLMT) (Yuet al., 2009)wasused to trans-
fect fibroblast cells. By day 10, a relatively large population
of SSEA4/TRA181-positive cells was detected (>1.0%, Fig-
ures S1AandS1B). This compared favorably to theefficiency
seen in other episomal-reprogramming systems (Narsinh
et al., 2011). We also noticed that the reprogramming col-
onies were extremely heterogeneous, placing further value
in the ability to sort and select individual cells compared
to traditional manual colony picking (Figure S1B). On day
14, the reprogramming culture supported by FRMwas split
into either FRM or FMM. On day 21, each culture was flow
cytometry sorted for SSEA4/TRA181/CD30-positive cells
(Figure S1C). Cultures maintained in FRM contained a
mixed population of differentiated and undifferentiated
cells, whereas the culture switched to FMM contained
mostly undifferentiated cells (Figure S1D).
In order to explore the throughput and robustness of this
approach, we applied it to different somatic parental lines
sourced as either fibroblasts or CD34+ cells expanded
from mobilized peripheral blood or minimal volumes of
umbilical cord blood from donors of different ages, gen-
ders, and ethnicities (Figures S2A and S2B). Each line was
induced to reprogram as outlined in Figure 2A with the
episomal gene combination set OSNKLMT and 96-well
plate flow cytometry sorted for individual hiPSCs (Figures
2B, S2C, and S2D). A large population of SSEA4/TRA181/
CD30-positive cells was observed for the majority of our
reprogramming lines, and the effectiveness of the FRM
and FMM system was further highlighted when compared(E) Colony counts of day 36 staining as discussed in (D): p < 0.0005 bet
independent experiments were performed for conventional (Conv.) and
to FMM and SMC4, with an SEM.
See also Table S1.
Stem Cto a parallel reprogramming experiment using conven-
tional medium and feeder cells (8.55% in FRM/FMM versus
0.02% in conventional culture for the FTC007 fibroblast
line; Figures 2B and 2C). On average, 22 clonal hiPSCs
per 96-well plate were seen for each somatic line (Figures
2B, S3A, and S3B). Colonies were subsequently confirmed
as bona fide hiPSC clones by direct analysis of intracellular
and surface marker expression and direct quantitative real-
time PCR for NANOG (Figures 2D, 2E, and S3C). A similar
reprogramming efficiency was observed with the defined
surface coating Vitronectin (Figure S3D). This data set dem-
onstrates that the platform is robust and reproducible
when applied to episomal reprogramming, including in
single-cell and FF culture, and allows for multiple reprog-
ramming experiments to be performed in parallel with
minimal effort and without compromising quality.
Long-Term Passage and Expansion of Transgene-free
hiPSC Lines in FMM
In order to assess the long-term passage and expansion of
hiPSCs in our FMM platform, clones selected from the re-
programming study were expanded as single cells in FF cul-
ture (Figures 3A and S3E). hiPSC lines seen to have lost
episomal DNA by passage 4–7 were carried forward for
analysis (Figure 3B). Quantitative real-time PCR analysis
of pluripotency markers confirmed the undifferentiated
state of selected hiPSC lines, with KLF4 expression being
noticeably elevated (Figure 3C). Immunofluorescence
expression and flow cytometry analyses also showed hiPSC
lines to maintain a homogeneous population of undiffer-
entiated cells (Figures 3D and 3E). The homogeneity of
culture was maintained without the need of any cleanup
strategies that are commonly utilized in pluripotent
culture, such as the manual separation of differentiated
from undifferentiated colonies. Similar expansion of uni-
form hiPSC cultures was observed when Matrigel was re-
placed with the defined surface coating Vitronectin during
routine single-cell passaged culture (Figures S3F–S3H).
Genomic abnormalities are often detected in hESC and
hiPSC lines passaged as single cells in a FF environment
(Laurent et al., 2011; Taapken et al., 2011). Importantly,
hiPSC clones single-cell and FF cultured in FMM for an
extended period (25–30 passages) continued to maintain
their undifferentiated profile and genomic stability
without the need for culture cleaning or further selection
(Figures 4A and 4B). When induced to differentiate,
episomal-derived hiPSC clones maintained in FMM readily
gave rise to all three somatic lineages (Figures 4C–4E).ween SMC4 versus SMC4 to FMM OCT4/NANOG colony number. Two
FMM, and three independent experiments were conducted for SMC4
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Figure 2. Individual Episomal-Reprogrammed hiPSCs Are Efficiently Selected and Seeded in 96-Well Plates for Clonal Expansion
(A) Schematic timing illustration of episomal induction, multistage media system, flow cytometry sorting, and clonal expansion.
(B) Flow cytometry profile of episomal-induced reprogramming maintained in FRM-to-FMM transition in FF culture (outlined in A) at
indicated days post-transfection. Sort-gating strategy used for each parental line (SSEA4+/TRA181+/CD30+ population) is illustrated in
(legend continued on next page)
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Transgene-free hiPSCs Resembling the Ground StateEnabling Episomal Reprogramming with Minimal
Genes
Having demonstrated an extremely efficient and robust
platform for the generation and expansion of transgene-
free hiPSCs using OSNKLMT-reprogramming factors, we
next wanted to test if this same system could enable
hiPSC generation without the requirement for many re-
programming factor genes. An efficient footprint-free
expression system with the reduced dependency for
oncogenes such as KLF4, MYC, and LIN28 or the need
to knock down P53 during the reprogramming process
would be of great value for pluripotent stem cell therapies
(Lee et al., 2013; Okita et al., 2011; Yu et al., 2009). We
therefore constructed several episomal expression cassettes
lacking the oncogenic-reprogramming factors and con-
taining minimal gene sets including OCT4/NANOG/SOX2
(ONS), OCT4/SOX2 (OS), or OCT4/OCT4 (2xO) in an
attempt to vary gene expression combination and dosage
(Figure S4A).
Reprogramming of fibroblast line FTC007 with various
combinations of OCT4, NANOG, SOX2, and SV40LT was
attempted in the FRM, FMM, and flow cytometry selection
platform as previously described (Figure 2A). Although
SV40LT alone did not produce any true SSEA4/TRA181-
positive cells at day 13 of reprogramming, it was seen to
be necessary for improved cell survival post-transfection
(Figures 5A and S4B). The various reprogramming factor
combinations, including justOCT4/SOX2/SV40LT, resulted
in efficient reprogramming as demonstrated by the
emergence of SSEA4/TRA181-positive populations early
in the reprogramming process (Figure 5A). Surprisingly,
the percentages observed were on par with lentiviral and
episomal-induced systems containing KLF4 and MYC
(Figures 2B, 5A, and S4C). Several reprogramming factor
combinations were carried forward and transitioned to
FMM prior to flow cytometry sorting and selection of indi-
vidual hiPSC clones. Similar to OSNKLMTepisomal reprog-
ramming, clonal hiPSC lines were readily derived from
combinations containing minimal genes OCT4, SOX2,
and SV40LT as well as other combinations (Figure 5B).respective colors, corresponding to the bottom histogram panel re
individual hiPSC clones. Wells containing multiple clones or differe
were performed with an SEM. The solid line represents the average pe
22.3 ± 5.5.
(C) Flow profile of FTC007 induced to reprogram 19 days posttransfecti
The induced population is taken from the same population of FTC007
(D) Immunocytochemistry analysis of various pluripotency markers of
staining. Scale bar, 500 mm.
(E) Quantitative real-time PCR for NANOG expression for each well of a S
per well. The expression range is between zero and four times expressi
the right side and normalized to GAPDH.
See also Figures S1, S2, and S3.
Stem CThe hiPSC clones that were demonstrated to be negative
for transgenes and episomal vector markers by passages
5–7 were carried forward for further analysis (Figure 5C).
To provide further evidence for the absence of episomal
DNA in hiPSC lines, we conducted a functional test for
survival in the presence of hygromycin. Various FCT007-
derived hiPSC lines (seen to be karyotype normal while
maintaining pluripotency, Figures 2, 3, 4, and 5) were
treated with hygromycin at or above the kill concentration
(50 and 100 mM, respectively, Figures S4D–S4F). Although
survival was seen at both concentrations for the reprogram-
ming pool, none of the tested hiPSC lines demonstrated
resistance to hygromycin, indicative of complete loss of
episomal DNA (Figures S4E and S4F).
Selected clones were continuously passaged as single
cells in a FF environment and were demonstrated to main-
tain a homogeneous population of undifferentiated cells,
while displaying the ability to efficiently differentiate
into the three somatic lineages (Figures 5E–5H). Karyotype
and copy number variation analysis revealed genomically
stable hiPSC lines during long-term culture maintained in
FMM (Figures 5I and 5J). Collectively, the data show that
hiPSCs can be readily generated by transient expression
of minimal reprogramming genes from episomal systems
in the FRM/FMM, flow cytometry-based-reprogramming
platform, including a combination consisting of only
OCT4, SOX2, and SV40LT.
FMM Supports hiPSC Properties Resembling the
Ground State of Pluripotency
We next investigated the gene expression differences
between small molecule and conventionally maintained
hiPSC cultures (Hanna et al., 2010b; Saha and Jaenisch,
2009). In an initial study, a lentiviral-induced hiPSC clone
FTi111 generated and maintained in small molecule
culture and shown to be pluripotent was thawed directly
into various culture environments (Figures S5A–S5C).
During three passages, each culture set demonstrated
unique colony morphology (Figure S5D). Interestingly,
gene expression of pluripotent markers revealed a distinctpresenting the percentage of wells of 96-well plate containing
ntiated clones were not scored. Three independent experiments
rcentage among all derivations with dotted lines representing SD,
on maintained in conventional medium in the presence of MEF cells.
in (B), however, treated in different culture thereafter.
sorted colonies in 96-well plate. Right corner panels represent DAPI
SEA4/TRA181/CD30 direct sorted (FACS) 96-well plate at three cells
on relative to H1 human ESCs as described in the legend located on
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Figure 3. Episomal-Reprogrammed hiPSC Clones Maintain Their Undifferentiated State and Are Free of Transgene Sequence
(A) Representative images of hiPSC clone during culture. Scale bars, 1,000 mm.
(B) PCR analysis for episomal DNA derived from various hiPSC clones. Lane 1 shows FTC007-c1 p4, lane 2 shows FTC007-c21 p4, lane 3 shows
FTC016-c25 p5, lane 4 shows FTC016-c36 p5, lane 5 shows FTC017-c11 p7, lane 6 shows FTC017-c14 p7, lane 7 shows FTC017-c17 p6 (a line
maintaining episomal constructs used a positive control), lane 8 shows untransfected FTC007, lane 9 shows hiPSC generated using
lentiviral constructs, and lane 10 shows episomal vector used as positive control. Input of 100 ng genomic DNA and 35 PCR cycles were
used for all sets.
(C) Quantitative real-time PCR analysis for endogenous pluripotent gene expression. Data were normalized to GAPDH and relative to HUES9
hESCs. Four independent experiments were performed, with an SEM.
(D) Pluripotency markers detected by immunofluorescence. Scale bar, 200 mm.
(E) Flow cytometry profile for selected hiPSC clones from various parental lines.
See also Figure S3.
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Figure 4. Genomic Stability and Pluripotency Are Maintained during Continuous Single-Cell and FF Culture
(A) Cytogenetic analysis on 20–40 G-banded metaphase cells from various hiPSC clones maintained in FF and single-cell culture.
(B) Flow cytometry profile and cytogenetic analysis of long-term-passaged hiPSC clones in FF and single-cell enzymatic-passaged culture.
(C) Three to 4-day-directed differentiation of FTC017-c11. Scale bar, 200 mm.
(D) Embryoid body formation and differentiation. Immunocytochemistry was conducted 28 days post-differentiation: ectoderm, Tuj1;
mesoderm, a smooth muscle actin (aSMA); and endoderm, AFP. Scale bars, 1,000 mm (bright-field images), 200 mm (TUJ1 images), and
500 mm (SMA and AFP images).
(E) Histological sections of teratoma derived from FTC007-c21 and FTC016-c25. Black arrows point to endoderm, white arrows point to
ectoderm, and gray arrows point to mesoderm. Scale bar, 200 mm.
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Transgene-free hiPSCs Resembling the Ground Statepattern between the culture environments (Figure S5E).
Although derived from the same thaw, the conventionally
maintained culture on feeder cells better resembled hESC
control H1 maintained in conventional culture than its
counterpart cultures maintained in small molecules
(Figure S5E). Both small molecule cultured sets appeared
to have elevated gene expression of certain pluripotency
genes, including KLF4, whereas other genes such as
LIN28 and DPPA4 appeared to be similar between the
culture systems (Figure S5E). The differentiation marker,
PAX7, appeared to be nearly silenced when hiPSCs were
cultured with small molecules in FF culture (Figure S5E).
Continuing these observations, differences between
hiPSCs derived using lentiviral induction and conven-
tional hESC/feeder culture and episomal lines derived
with different combinations of reprogramming factors
maintained in the FRM/FMM platform were assessed.
High-content quantitative real-time PCR analysis was
used to explore gene expression associated with pluripo-
tency and differentiation. Themajority of the pluripotency
genes surveyed displayed a similar expression pattern
between hiPSCs maintained in FMM culture or conven-
tional cultures containing feeder cells regardless of the
reprogramming method or gene combinations used in
their derivation; with the exception of KLF4 expression,
again seen to be elevated in small molecule-mediated
culture (Figure 6A). However, expression differences be-
tween cell lines were clearly observed in genes associated
with differentiation (Figure 6B). Regardless of the gene
combination used during induction, FMM-maintained
hiPSCs displayed lower expression ofmost genes associated
with the three somatic lineages when compared to
both hiPSCs and H1 hESCs maintained in conventional
medium and on feeder cells. A subset of lines induced
by episomal gene set OSNKLMT appeared to show expres-Figure 5. Derivation of hiPSC Clones with Minimal Number of Rep
(A) Flow cytometry profile of reprogramming kinetics induced by vari
(B) Histogram of hiPSC clones in wells of 96-well plate at three and n
with an SEM.
(C) PCR analysis for episomal DNA derived from various hiPSC clones. L
p6, lane 3 shows 2xO+ONS+T-c5 p5, lane 4 shows 2xO+ONS+T-c9 p5, l
shows untransfected FTC007, lane 8 shows hiPSC generated using lent
control. Input of 100 ng genomic DNA and 35 PCR cycles were used f
(D) Typical morphology. Scale bar, 1,000 mm.
(E) Pluripotency markers detected by immunofluorescence. Scale bar,
(F) Flow profile of hiPSC clones.
(G) Directed differentiation of selected hiPSC clones 72–96 hr post-i
(H) Histological sections of teratoma derived from hiPSC clone 2xO
mesoderm, and right panel shows ectoderm. Scale bar, 200 mm.
(I) Cytogenetic analysis of 20 G-banded metaphase cells from variou
(J) Copy number variation as assessed by array-comparative genomic
summary of the data. CNV, copy number variation.
See also Figure S4.
Stem Csion of ectoderm lineage, OTX2 and TUJ1, whereas this
expression was negligible in the hiPSCs episomally derived
without the use of Lin28, KLF4, and c-MYC (Figure 6B). The
expression of all differentiation genes tested was fully
suppressed in all hiPSCs derived from episomal minimal
gene sets and maintained in FMM (Figure 6B).
We next assessed whether hiPSCs derived and main-
tained in from various media could be defined by patterns
in global gene expression analyses. We compared (1)
episomal induction maintained in FMM, (2) episomal
induction maintained in FMM but switched to conven-
tional medium for three passages, (3) lentiviral induction
maintained in SMC4, and (4) lentiviral induction main-
tained in conventional culture (Figures S6A and S6B). All
lines had previously been demonstrated to be pluripotent,
genomically stable, and able to differentiate to all three
somatic lineages. Cluster analysis of genes differentially
expressed between small molecule culture and con-
ventional culture revealed that the hiPSC lines grouped
based on current culture conditions, and not by original
derivationmethod and culture (Figure S6B). Gene ontology
classification of 300 genes displaying 2.5-fold expression
differences identified differentiation and development as
the main categories highly enriched in the conventional
culture group, whereas genes upregulated in the small
molecule culture groupweremostly associated with regula-
tion of cell proliferation and sex development (Figures S6C
and S6D). Gene expression analysis was repeated with
direct comparison of cultures in FMM, conventional, or
transitions from each culture to the other (FMM, Conv,
FMM/Conv, Conv/FMM; Figure S6A). Again, cluster
analysis produced two groups separated based on the
current culture system regardless of method of generation
or the prior culture system (Figure 7A). For example,
FTC016-c28 (FTC016-derived hiPSC clone 28) wasrogramming Factors
ous gene combinations at day 13 post-induction.
ine cells per well. Three independent experiments were performed,
ane 1 shows 2xO+OS+ONS+T-c7 p6, lane 2 shows 2xO+OS+ONS+T-c10
ane 5 shows 2xO+OS+T-c7 p6, lane 6 shows 2xO+OS+T-c9 p6, lane 7
iviral constructs, and lane 9 shows episomal vector used as positive
or all sets.
1,000 mm.
nduction. Scale bar, 500 mm.
+OS+ONS+T-c10. Left panel shows endoderm, middle panel shows
s hiPSC clones maintained in FF and single-cell culture.
hybridization and SNP. Panel on the right represents interpretation
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Figure 6. Relative Gene Expression Profile of Minimal Factor Episomal-Induced hiPSCs in FMM
(A and B) Heatmap results derived from a Fluidigm dynamic array depicting relative gene expression levels of pluripotency (A) and
differentiation (B) genes of conventionally maintained hiPSC lines, RNA from conventionally maintained H1 hESCs, and episomal hiPSC
lines derived using various gene combinations maintained in FMM. Relative gene expression for each line is noted within each box and
color coded based on three expression levels summarized in the legend (lower right). All sets were normalized to the average expression of
two housekeeping genes (GAPDH and HPRT1) and referenced to the median expression level of six control conventional lines (OSK hiPSCs
and H1 hESCs on MEF) representing 13 value for each gene. See also Figure S5.
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prior to transition to conventional culture (Epi-FTC016-
c28: FMM/Conv). When analyzed, it grouped with cul-
tures maintained exclusively in conventional culture, and
not with its parental line maintained in FMM. The inverse
was also seen: lines generated in conventional culture
grouped within the conventional set until transition to376 Stem Cell Reports j Vol. 2 j 366–381 j March 11, 2014 j ª2014 The AuthFMM, upon which it grouped within the FMM cluster
(Figure 7A). Gene ontology once again categorized con-
ventional culture to be enriched with genes associated
with differentiation and development (i.e., p = 2.2 3
1010, pattern specification process; Figures 7B and S6E).
These results suggest that genes associated with differenti-
ation propensity are reduced in FMM culture, and hiPSCsors
Stem Cell Reports
Transgene-free hiPSCs Resembling the Ground Statecan be adapted to this system to reduce spontaneous differ-
entiation potential.
With the demonstrated high survival rates in single-cell
dissociation and significant suppression of differentiation-
related gene expression, we examined if FMM was
supporting the ground state of human pluripotent stem
cells by blocking pathways associated with differentiation
(Ying et al., 2008). Gene lists were compiled to represent
ground and metastable states of human pluripotent stem
cells (De Los Angeles et al., 2012; Han et al., 2011; Hanna
et al., 2010a; Hirata et al., 2012; Nichols and Smith, 2012;
Valamehr et al., 2012; Zhou et al., 2010) (Figure 7C). Gene
clustering based on these gene lists was then performed
for hiPSC lines in FMMor conventional culture (Figure 7D).
Similar to the global gene expression comparison, the
focused gene clustering showed a clear separation of the
cell lines based on their current culture conditions with
profiles appearing to be interconvertible. For example,
FTC016-c28 transitioned from FMM to conventional
culture grouped with H1 hESCs and not with its parental
hiPSC linemaintained in FMM (Figure 7D). Similarly, a len-
tiviral hiPSC clone derived from a fibroblast line (6F Lenti-
hiPSC-c3) maintained in conventional culture grouped
withHUES9 hESCs and other hiPSC clones in conventional
culture; however, when switched to FMM, it grouped with
an episomal hiPSC derived from umbilical cord blood as
well as other FMM-cultured lines (Figure 7D). To determine
the distribution of genes representative of the ground and
metastable states within the two clusters, we plotted
average intensities for each probe set with respect to small
molecule (FMM/SMC4) versus conventional culture (Fig-
ure 7E). Interestingly, the majority of genes associated
with the ground statewere seen to have elevated expression
in small molecule culture cluster, whereas an increase in
expression of genes associated with metastable state was
detected in the conventional culture cluster (Figure 7E).
We next analyzed the X-inactivation state of female
hiPSCs derived and maintained in conventional culture
conditions compared to its counterpart adapted to small
molecule culture and maintained for ten passages (Fig-
ure 7F). hiPSCs maintained in small molecule culture re-
vealed anotable increase inXchromosomegene expression
when compared to conventional culture, suggestive of reac-
tivation of the silenced X chromosome (Figure 7F). The
noticeable exception was the X-inactive-specific transcript
(XIST), the major effector of X inactivation, which was
downregulated in the switch to smallmolecule culture (Fig-
ure 7F). Further evidence of X activation was provided by
the differential staining of H3K27me3 in hiPSCs cultured
in FMMrelative to their counterpart culture adapted to con-
ventional medium (<10% H3K27me3 staining in FMM
compared to >90% H3K27me3 staining in conventional
culture; Figure 7G). Collectively, these data suggest thatStem CFMM represses differentiation cues and in turn promotes
features associated with the ground state of pluripotency.DISCUSSION
Here, we describe a multistage process for highly efficient
nonintegrative cellular reprogramming coupled to a
method of scalable hiPSC culture that utilizes stage-specific
media formulations: FRM for enhanced reprogramming,
and FMM for long-term maintenance. Previous studies
have demonstrated the versatility of small molecules in
the reprogramming and maintenance of pluripotent stem
cells of various species (Nie et al., 2012). However, to
date, no small molecule-driven platform has demonstrated
the ability to enhance reprogramming and support single-
cell and FF culture of footprint-free iPSCs derived from
human cells (Nichols and Smith, 2012). We show that
the application of specific combinations of small molecule
inhibitors in a stage-specific manner is key to enabling
robust reprogramming and long-term culture. Studies
have indicated that a reprogramming cell population is
uniform in the early stages withmajor variations occurring
thereafter (Polo et al., 2012). This suggests that counteract-
ing lineage-specifying pathways early could facilitate the
reprogramming process (Polo et al., 2012; Shu et al.,
2013). Mesenchymal-to-epithelial transition (MET) has
also been shown to support nuclear reprogramming (Li
et al., 2010). By blocking differentiation cues early in the
reprogramming process and promotingMET through small
molecule inhibition of specific pathways, the efficiency of
hiPSC generation was significantly improved using the
FRM. Indeed, the use of the FRM resulted in robust reprog-
ramming using episomal vectors, in FF and single-cell
culture systems, including a demonstration of OCT4/
SOX2/SV40LT-only episomal reprogramming.
Many ambitious hiPSC banking efforts are currently
underway, with the goal of deriving populations of cells
from different genetic and disease backgrounds (Rao,
2013). The derivation of footprint-free hiPSCs from various
parental somatic sources in amultiplexmanner has proven
to be difficult and laborious (Narsinh et al., 2011; Saha and
Jaenisch, 2009). By significantly improving the efficiencyof
episomal-induced reprogramming and selecting bona fide
hiPSCs by direct flow cytometry sorting into 96-well plate
formats at clonal density, cell line generation and character-
ization can be multiplexed. This system enables a single
researcher to parallel reprogram multiple somatic lines
usingminimal starting cell material and derivemany trans-
gene-free hiPSC clones in single-cell, FF culture systems
with minimal effort and in an expedited time frame.
Long-term passage of pluripotent stem cells in environ-
ments applicable to scaled cell production is hampered byell Reports j Vol. 2 j 366–381 j March 11, 2014 j ª2014 The Authors 377
(legend on next page)
378 Stem Cell Reports j Vol. 2 j 366–381 j March 11, 2014 j ª2014 The Authors
Stem Cell Reports
Transgene-free hiPSCs Resembling the Ground State
Stem Cell Reports
Transgene-free hiPSCs Resembling the Ground Statespontaneous differentiation and genomic instability (Lau-
rent et al., 2011; Taapken et al., 2011). Preventing sponta-
neous differentiation while increasing clonality with the
use of small molecules has been demonstrated in both
mouse and human pluripotent stem cells; however, the
latter required ectopic expression of several pluripotency
genes resulting in genetic manipulation (Hanna et al.,
2010a; Ying et al., 2008). These cells represent the ground
state of pluripotency that is associated with a capacity to
give rise to all cell types and expression of unique genes
associated with core pluripotency (Hanna et al., 2010b;
Nichols and Smith, 2012). The more developmentally
advanced stage of pluripotency representing the meta-
stable state has been associated with human pluripotent
stem cell cultures and is defined by properties that include
spontaneous differentiation, high rate of cell death upon
single-cell dissociation, and the inability to give rise to all
somatic cell types (Nichols and Smith, 2012).We identified
inhibition of TGF-b as a contributing factor in the sponta-
neous differentiation observed in long-term passage of
transgene-free hiPSCs. FMM does not include a TGF-b
inhibitor and is able to support the continuous mainte-
nance of footprint-free hiPSCs passaged as single cells in a
FF environment without the additional requirement of
transgene expression. These media and culture systems
facilitate culture practices for everyday users, such as
removing the requirement for clump passaging, daily
culture feeding, or culture cleaning, and therefore deliver
a robust basis for a scaled manufacturing process, relevant
for future cell therapy applications. We demonstrate that
the genomic stability ofmultiple transgene-free hiPSC lines
is supported by FMM after long-term single-cell enzymaticFigure 7. FMM-Maintained hiPSCs Have Reduced Expression of Diff
with the Ground State
(A) A total of 339 probe sets were differentially expressed between
Hierarchical clustering on the 339 probe sets using a complete linkage
Conventional culture is noted in blue, and FMM culture is noted in br
(B) Gene ontology biological process enrichment analysis (D.A.V.I
conventional culture (in comparison to FMM culture).
(C) Gene lists representative of ground or metastable pluripotency st
(D) Hierarchical clustering on the 227 probe sets corresponding to th
distance measurements.
(E) RMA (log2)-normalized intensities for the probe sets correspondin
state; right panel represents 188 probe sets for metastable state. Ave
whereas the average FMM/SMC4 intensity is on the y axis, and black
(F) Gene expression comparison of X chromosome-located genes betwe
and its counterpart adapted to SMC4 culture using all 1,688 Affymetrix
XIST gene expression are highlighted.
(G) Representative images of HEK27me3 on hiPSC clone maintained i
arrow in the left panel points to a representative nucleus absent of H3
nucleus positive for H3K27me3 staining. Percentages of nucleus-posit
bar, 50 mm.
See also Figures S5 and S6.
Stem Cpassages in a FF culture environment. This improved
viability and stability in single-cell culture will be particu-
larly useful in hiPSC applications such as selection of
genomic modifications in disease-correction studies (Saha
and Jaenisch, 2009). Collectively, our data suggest that
hiPSCs cultured in FMM portray properties commonly
associated with the ground state as demonstrated by fea-
tures such as repression of differentiation gene expression
and high clonality; however, additional studies will be
necessary to confirm these observations (De Los Angeles
et al., 2012; Hanna et al., 2010a, 2010b; Ying et al., 2008).
The potential FMM-induced ground state is seen to be inde-
pendent of transgene expression but also appears to be in-
dependent of derivationmethod, source of parental line, or
previously maintained culture conditions. These qualities
are lost when hiPSCs are switched from FMM to conven-
tional culture (FMM/Conv) but gained when switched
from conventional culture to FMM (Conv/FMM), sug-
gesting that the ground state may be interconvertible as
seen previously with mouse pluripotent stem cells (Marks
et al., 2012). Two recent advancements inmouse iPSC tech-
nology include the elimination reprogramming factors in
deriving mouse iPSCs and synchronizing the reprogram-
ming process to nearly perfect efficiencies (Hou et al.,
2013; Rais et al., 2013). The need for optimal culture condi-
tions, i.e., 2i, was an important requirement for the success
of both of these studies. FMM may represent the human
pluripotent stem cell version of 2i and help accelerate the
success of current studies. During the preparation of this
manuscript, two studies demonstrated the maintenance
of pluripotent stem cells in the ground state or resembling
preimplantation epiblast using unique small moleculeerentiated Genes and Increased Expression of Genes Associated
conventional and FMM culture by greater or less than 2.5-fold.
method based on Euclidean distance measurements was performed.
own.
.D.) of the 213 probe sets upregulated 2.5-fold or greater with
ates. List is derived from references noted in text.
e genes in (C) using a complete linkage method based on Euclidean
g to the genes in (C). Left panel represents 39 probe sets for ground
rage conventional culture intensity levels are plotted on the x axis,
line indicates equal expression.
en hiPSC clone derived and cultured in conventional medium culture
probe sets mapped to the X chromosome. Probe sets associated with
n FMM or adapted to conventional culture for five passages. Dotted
K27me3 staining, whereas solid arrow in the right panel points to a
ive staining are indicated in the lower-left side of each panel. Scale
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Transgene-free hiPSCs Resembling the Ground Statecocktails with similar pathway inhibition as utilized in
FMM (Chan et al., 2013; Gafni et al., 2013).
The goal of the current study was to define a platform
that enables hiPSC derivation and maintenance to the
point where reprogramming is no longer a source of
variability and/or gating activity for downstream cell line
use. The FRM/FMM-multistage platform represents an
advanced method for derivation and maintenance of
hiPSCs that is amenable to all users. This study aims to
serve as a resource and a blueprint for the derivation and
maintenance of hiPSCs that are appropriate for industrial
and clinical use.EXPERIMENTAL PROCEDURES
Animal Handling and Maintenance
Fate Therapeutics complies with all applicable provisions of the
AnimalWelfare Act and has established andmaintained a program
for activities involving animals in accordance with theNIH ‘‘Guide
for the Care and Use of Laboratory Animals.’’
hiPSC Maintenance in Small Molecule Culture
Derived hiPSCs were routinely passaged as single cells once conflu-
ency of the culture reached 75%–90%.Overconfluencywas seen to
exhaust the medium and result in differentiation. For single-cell
dissociation, hiPSCs were washed once with PBS (Mediatech) and
treated with Accutase (Millipore) for 3–5 min at 37C followed
with pipetting to ensure single-cell dissociation. The single-cell
suspension was then mixed in equal volume with conventional
medium, centrifuged at 225 3 g for 4 min, resuspened in FMM,
and plated on Matrigel-coated surface. Passages were typically
1:6–1:8, transferred tissue culture plates previously coated with
Matrigel for 2–4 hr in 37C or Vitronectin for 1 hr at 25C and
fed every 2–3 days with FMM. Cell cultures were maintained in a
humidified incubator set at 37C and 5% CO2. Medium formula-
tions for FMM and FRM are described in Table S1. SMC4 culture
is discussed previously (Valamehr et al., 2012).
ACCESSION NUMBERS
The Gene Expression Omnibus (GEO) accession number for the
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GEO accession number for the Array Comparative Genomic
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